Pulse Biosciences (PLSE) Cash from Operations (2015 - 2025)
Pulse Biosciences (PLSE) posted quarterly Cash from Operations of 14755000.0 for Q4 2025, down 61.36% year-over-year from 38188429.1 in Q4 2024, and down 13.16% quarter-over-quarter from 13039000.0 in Q3 2025.
Pulse Biosciences (PLSE) Cash from Operations (2015 - 2025) Analysis & Trends
Pulse Biosciences' Cash from Operations history runs 11 years deep, the most recent figure standing at 14755000.0 for Q4 2025.
- In Q4 2025, Cash from Operations fell 61.36% year-over-year to 14755000.0; the TTM figure through Dec 2025 stood at 54122000.0 (down 48.92% YoY), while the FY2025 annual figure was 54122000.0, down 48.92% from the prior year.
- Cash from Operations for Q4 2025 stood at 14755000.0, down from 13039000.0 in the prior quarter.
- The five-year high for Cash from Operations was 6570000.0 in Q1 2023, with the low at 16366000.0 in Q2 2021.
- The 5-year median for Cash from Operations is 11159500.0 (2021), against an average of 11230800.0.
- The sharpest annual moves came in 2021 and 2023: Cash from Operations tumbled 106.15% in 2021, then jumped 57.87% in 2023.
- Pulse Biosciences' Cash from Operations stood at 12694000.0 in 2021, then soared by 37.25% to 7965000.0 in 2022, then grew by 14.85% to 6782000.0 in 2023, then plunged by 34.83% to 9144000.0 in 2024, then sank by 61.36% to 14755000.0 in 2025.
- Business Quant data shows PLSE's Cash from Operations at 14755000.0 in Q4 2025, 13039000.0 in Q3 2025, and 12807000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.06 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 776.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 454.63 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 715.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 124.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 227.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 182.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 297.00 Mn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.76 Mn |
| Dec 31, 2025 | -14.76 Mn |
| Sep 30, 2025 | -13.04 Mn |
| Sep 30, 2025 | -13.04 Mn |
| Jun 30, 2025 | -12.81 Mn |
| Jun 30, 2025 | -12.81 Mn |
| Mar 31, 2025 | -13.52 Mn |
| Mar 31, 2025 | -13.52 Mn |
| Dec 31, 2024 | -9.14 Mn |
| Dec 31, 2024 | -9.14 Mn |
| Sep 30, 2024 | -9.02 Mn |
| Sep 30, 2024 | -9.02 Mn |
| Jun 30, 2024 | -8.40 Mn |
| Jun 30, 2024 | -8.40 Mn |
| Mar 31, 2024 | -9.78 Mn |
| Mar 31, 2024 | -9.78 Mn |
| Dec 31, 2023 | -6.78 Mn |
| Dec 31, 2023 | -6.78 Mn |
| Sep 30, 2023 | -10.49 Mn |
| Sep 30, 2023 | -10.49 Mn |